Posts Categorized: MS News

MS drug ‘may already be out there’

Source BBC: Depression and heart-disease drugs are to be tested in a trial to find treatments for Multiple Sclerosis (MS) from existing medicines. There are currently no treatments in the secondary progressive stage of the debilitating disease. More than 400 people will take part in the trial at University College London and the University of… Read more »

We need MS specialists at the heart of MS care

Source MS Trust: We’ve been working to train and support MS specialists, helping them demonstrate the value of their work, and working to change national guidance. But we need your help. If you agree that people living with MS should have access to the best possible care, lend your voice to our campaign: sign up… Read more »

Salt: no great shakes for your health

Source: The Guardian We have known for some time that too much is bad for us, but now researchers are linking increased salt consumption to the rise in autoimmune disease.  Read on.

PML case confirmed in someone taking Gilenya

Source MS Society: Novartis, who manufacture Gilenya (fingolimod), have confirmed a case of the rare brain infection PML (progressive multifocal leukoencephalopathy) in someone taking the drug.  Read on.

We need MS specialists at the heart of MS care

Source MS Trust: We’ve been working to train and support MS specialists, helping them demonstrate the value of their work, and working to change national guidance. But we need your help. If you agree that people living with MS should have access to the best possible care, lend your voice to our campaign: sign up… Read more »

PML case confirmed in someone taking Gilenya

Source MS Society: Novartis, who manufacture Gilenya (fingolimod), have confirmed a case of the rare brain infection PML (progressive multifocal leukoencephalopathy) in someone taking the drug.  Read on.

MS-SMART trial for secondary progressive MS underway

Source MS Society: MS-SMART, a phase 2 clinical trial into progressive MS, has begun. It will investigate whether treatments that are already being used for other conditions could slow or halt disability progression in people with secondary progressive MS.  Read on.

Promising results for stem cell therapy in MS

Source News-medical.net:Preliminary findings suggest that nonmyeloablative haematopoietic stem cell transplantation (HSCT) may arrest, or even reverse, the progress of disease among patients with relapsing–remitting multiple sclerosis (MS). Read on.